[1] LIU F, SUN Q, BA RR, et al.Content Analysis and Comparative Study of Mecobalamin Capsules for Evaluation Sampling[J]. Journal of Pharmaceutical Research(药学研究), 2021, 40(2): 91-93. [2] National Medical Products Administration. Datasearch[EB/OL].[2024-08-27]. https://www.nmpa.gov.cn/datasearch/search-result.html. [3] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China, Volume II(中华人民共和国药典二部)[M]. Beijing: China Medical Science Press, 2020. [4] The United States Pharmacopeial Convention. U.S. Pharmacopeia 43/National Formulary 38[M]. Baltimore: United Book Press, 2020. [5] The Japanese Pharmacopoeia Commission. Japanese Pharmaco-poeia18[M]. Tokyo: Ministry of Health, Labour and Welfare, 2021. [6] LIU Y, GENG Y, QIN L, et al.Research Routes of Hygroscopicity of Chemical Reference Substances[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2024, 21(3): 280-282, 289. [7] LIU Y, GUO XH, QIN L, et al.Study on Hygroscopicity of Raw Material for Mecobalamin Reference Substance[J]. Chinese Pharmaceutical Affairs(中国药事), 2023, 37(8): 961-965. [8] LIU Y, WU JM, YAN J.Hygroscopicity Study of Vitamin B12 Chemical Reference Substance[J]. Chinese Pharmaceutical Journal(中国药学杂志), 2019, 54(10): 809-812. [9] SU B, ZHANG BX, BI YC, et al.Development of National Primary Purity Certified Reference Material of Caffeic Acid[J]. Herald of Medicine(医药导报), 2023, 42(8): 1192-1198. [10] FENG YC, PEI WL, NING BM, et al.Development and Application of Chemical Reference Materials[J]. Journal of China Pharmaceutical University(中国药科大学学报), 2024, 55(5): 715-720. [11] REN CW, LU Y.Study on Detection of Related Substances in Mecobalamin Injection[J]. Food and Drug(食品与药品), 2023, 25(6): 527-531. |